Masayuki Shimojima - Infectious Diseases

Author Information

Masayuki Shimojima is a prominent researcher in the field of Infectious Diseases, currently serving as the Chief of the Special Pathogens Laboratory at the Department of Virology I, National Institute of Infectious Diseases in Tokyo, Japan. His work is primarily based at the institute located at 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan. Masayuki Shimojima has made significant contributions to the study of viral infections, focusing on severe fever with thrombocytopenia syndrome (SFTS) and other related infectious diseases.

Research Contributions

Masayuki Shimojima has made substantial contributions to the study of infectious diseases, with a particular emphasis on severe fever with thrombocytopenia syndrome (SFTS) and other tick-borne viral infections. His research has explored various aspects of these diseases, including their pathological characteristics, diagnostic systems, and potential treatments. Notably, his work on the reverse genetics system for Heartland Bandavirus and the development of diagnostic systems for SFTS virus RNA detection from suspected infected animals demonstrates his commitment to advancing the understanding and management of these infectious diseases. His research also delves into the potential therapeutic effects of compounds like L-DOPA in inhibiting SFTS virus infection.

Aliases

Masayuki Shimojima is also known by several aliases, including M Shimojima and M. Shimojima.

Publication and Citation Metrics

Metric	Value
Total Citation Count	6573
h-index	38
Total Paper Count	185

Publications:

Reverse Genetics System for Heartland Bandavirus: NSs Protein Contributes to Heartland Bandavirus Virulence

DOI: 10.1128/jvi.00049-22

Year: 2022

A Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected from a Sick Dog with SFTS Virus Infection.

DOI: 10.7883/yoken.jjid.2021.796

Year: 2022

Co-infection with Severe Fever with Thrombocytopenia Syndrome Virus and Rickettsia japonica after Tick Bite, Japan

DOI: 10.3201/eid2704.203610

Year: 2021

Pathological Characteristics of Severe Fever With Thrombocytopenia Syndrome (SFTS) Virus in a Patient Infected With Sfts Virus From a Sick Cat’s Bite

DOI: 10.20944/PREPRINTS202101.0207.V1

Year: 2021

L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro.

DOI: 10.1016/j.jiac.2021.11.005

Year: 2021

M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening

DOI: 10.3390/v13061061

Year: 2021

Pathological Characteristics of a Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected with SFTS Virus through a Sick Cat’s Bite

DOI: 10.3390/v13020204

Year: 2021

Residual and Late Onset Symptoms Appeared in a Patient with Severe Fever with Thrombocytopenia in a Convalescence Stage

DOI: 10.3390/v13040657

Year: 2021

Diagnostic system for the detection of severe fever with thrombocytopenia syndrome virus RNA from suspected infected animals

DOI: 10.1371/journal.pone.0238671

Year: 2021

Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis

DOI: 10.1038/s41598-021-81752-0

Year: 2021

What is the global impact of Dengvaxia?

Who Should Get Regular Health Check-Ups?

How Is Muscle and Joint Pain Diagnosed in the Context of Infectious Diseases?

What are the Complications of HSV?

Are There Alternatives to Antipyretics?

How Are Respiratory Symptoms Diagnosed?

What is the Impact of Schistosomiasis Globally?

How Does Genomics Contribute to Vaccine Development?

What is a Rash?

How Can Individuals Support CDC's Efforts?

Partnered Content Networks

Relevant Topics